Physician profile
Morgan A Baxter
NPI 1518450733
$30,428.94
in general payments reported to CMS, 2019-2025
26 companies · $5,093 in 2025
The $5,093 reported for 2025 was more than what 93% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $743 · 2021: $10K · 2022: $11K · 2023: $2,166 · 2024: $933 · 2025: $5,093.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,369 · Food and Beverage: $2,823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,369.31 |
| Food and Beverage | $2,822.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mid-Atlantic Surgical Systems, LLC | $8,935.30 | 2020-2025 | |
| Arthrex, INC. | $7,134.10 | 2021-2025 | |
| Stryker Corporation | $6,221.51 | 2021-2025 | Citrefix, Prostep, Axsos |
| Treace Medical Concepts, INC. | $4,259.07 | 2021-2025 | |
| Vilex LLC | $2,038.98 | 2021 | |
| Dne LLC | $604.70 | 2022 | |
| Kerecis Limited | $215.11 | 2021 | |
| Axogen | $165.93 | 2021 | |
| Smith+Nephew, INC. | $165.56 | 2021-2024 | Stravix Pl, Grafix Pl |
| Zimmer Biomet Holdings, INC. | $131.41 | 2024 | Tapestry |
| Bioventus LLC | $83.45 | 2022-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Peerless Surgical INC. | $83.37 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $44.51 | 2025 | |
| Hydrofera LLC | $44.50 | 2024-2025 | Leukomed Sorbact, Hydrofera Blue |
| Paragon 28, INC. | $42.73 | 2024-2025 | Phantom Metatarsal Shortening, Phantom Fibula Nail, Mtp |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimvie INC. | $34.24 | 2022 | |
| Abbott Laboratories | $33.99 | 2025 | Proclaim |
| Depuy Synthes Sales INC. | $33.29 | 2025 | Motoband |
| Organogenesis INC. | $29.10 | 2024 | |
| Si-Bone, INC. | $25.40 | 2023 | |
| Paratek Pharmaceuticals, INC. | $24.33 | 2024 | Nuzyra |
| Acera Surgical, INC. | $18.75 | 2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $17.61 | 2022 | |
| Grt US Holding, INC. | $15.70 | 2021 | |
| Abbvie INC. | $13.80 | 2023 | Dalvance |
| Tenex Health INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Baxter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.